Equities

Sawai Group Holdings Co Ltd

Sawai Group Holdings Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)6,201.00
  • Today's Change121.00 / 1.99%
  • Shares traded229.50k
  • 1 Year change+34.78%
  • Beta0.6940
Data delayed at least 20 minutes, as of Sep 19 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments26,53533,25547,863
Total Receivables, Net57,20567,00765,059
Total Inventory100,002101,80585,853
Prepaid expenses------
Other current assets, total56,2433,2803,348
Total current assets239,985205,347202,123
Property, plant & equipment, net103,400121,330111,218
Goodwill, net------
Intangibles, net20,29927,09626,289
Long term investments8,7797,7917,223
Note receivable - long term------
Other long term assets5412,4282,303
Total assets382,024364,165349,502
LIABILITIES
Accounts payable26,53430,25428,665
Accrued expenses6,6097,3937,570
Notes payable/short-term debt12,84810,0000
Current portion long-term debt/capital leases4,5804,48314,706
Other current liabilities, total43,04733,02437,899
Total current liabilities93,61885,15488,840
Total long term debt69,69962,59056,522
Total debt87,12777,07371,228
Deferred income tax3372,0922,303
Minority interest5,36911,09510,016
Other liabilities, total3401,5911,754
Total liabilities169,363162,522159,435
SHAREHOLDERS EQUITY
Common stock10,02010,00010,000
Additional paid-in capital37,73437,71473,672
Retained earnings (accumulated deficit)150,042142,03298,954
Treasury stock - common(2)(2)(2)
Unrealized gain (loss)3,1852,2631,918
Other equity, total11,6829,6365,525
Total equity212,661201,643190,067
Total liabilities & shareholders' equity382,024364,165349,502
Total common shares outstanding444444
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.